nodes	percent_of_prediction	percent_of_DWPC	metapath
Masoprocol—IGF1R—Alzheimer's disease	0.823	1	CbGaD
Masoprocol—CYP2J2—blood vessel—Alzheimer's disease	0.00584	0.112	CbGeAlD
Masoprocol—IGF1R—embryo—Alzheimer's disease	0.00514	0.0987	CbGeAlD
Masoprocol—IGF1R—forebrain—Alzheimer's disease	0.00454	0.0873	CbGeAlD
Masoprocol—IGF1R—telencephalon—Alzheimer's disease	0.00418	0.0802	CbGeAlD
Masoprocol—CYP2J2—forebrain—Alzheimer's disease	0.00308	0.0592	CbGeAlD
Masoprocol—CYP2J2—telencephalon—Alzheimer's disease	0.00283	0.0544	CbGeAlD
Masoprocol—IGF1R—nervous system—Alzheimer's disease	0.00247	0.0474	CbGeAlD
Masoprocol—IGF1R—central nervous system—Alzheimer's disease	0.00237	0.0456	CbGeAlD
Masoprocol—IGF1R—cerebellum—Alzheimer's disease	0.00232	0.0446	CbGeAlD
Masoprocol—LTB4R—brain—Alzheimer's disease	0.00228	0.0439	CbGeAlD
Masoprocol—IGF1R—brain—Alzheimer's disease	0.00188	0.0362	CbGeAlD
Masoprocol—CYP19A1—forebrain—Alzheimer's disease	0.00168	0.0322	CbGeAlD
Masoprocol—CYP2J2—nervous system—Alzheimer's disease	0.00167	0.0321	CbGeAlD
Masoprocol—CYP2J2—central nervous system—Alzheimer's disease	0.00161	0.0309	CbGeAlD
Masoprocol—CYP2J2—cerebellum—Alzheimer's disease	0.00157	0.0302	CbGeAlD
Masoprocol—ALOX5—nervous system—Alzheimer's disease	0.00132	0.0253	CbGeAlD
Masoprocol—CYP2J2—brain—Alzheimer's disease	0.00128	0.0245	CbGeAlD
Masoprocol—ALOX5—central nervous system—Alzheimer's disease	0.00127	0.0244	CbGeAlD
Masoprocol—ALOX5—cerebellum—Alzheimer's disease	0.00124	0.0238	CbGeAlD
Masoprocol—ALOX5—brain—Alzheimer's disease	0.00101	0.0193	CbGeAlD
Masoprocol—CYP19A1—nervous system—Alzheimer's disease	0.00091	0.0175	CbGeAlD
Masoprocol—CYP19A1—central nervous system—Alzheimer's disease	0.000877	0.0168	CbGeAlD
Masoprocol—Dopamine—MAOB—Alzheimer's disease	0.000706	0.474	CrCbGaD
Masoprocol—CYP19A1—brain—Alzheimer's disease	0.000696	0.0134	CbGeAlD
Masoprocol—Dopamine—SLC6A4—Alzheimer's disease	0.000319	0.214	CrCbGaD
Masoprocol—L-DOPA—CYP2D6—Alzheimer's disease	0.000241	0.162	CrCbGaD
Masoprocol—Dopamine—CYP2D6—Alzheimer's disease	0.000224	0.15	CrCbGaD
Masoprocol—ALOX5—Metabolism of lipids and lipoproteins—ACHE—Alzheimer's disease	0.000114	0.000924	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism of lipids and lipoproteins—INPP5D—Alzheimer's disease	0.000113	0.000913	CbGpPWpGaD
Masoprocol—LTB4R—Signaling by GPCR—APP—Alzheimer's disease	0.000113	0.000912	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism of lipids and lipoproteins—BCHE—Alzheimer's disease	0.000112	0.000903	CbGpPWpGaD
Masoprocol—LTB4R—GPCR ligand binding—CCL2—Alzheimer's disease	0.000111	0.000898	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—HSD17B10—Alzheimer's disease	0.00011	0.000885	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—PSENEN—Alzheimer's disease	0.000109	0.000882	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—APH1A—Alzheimer's disease	0.000108	0.000869	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism of lipids and lipoproteins—PTGS1—Alzheimer's disease	0.000107	0.000865	CbGpPWpGaD
Masoprocol—LTB4R—Signaling by GPCR—PLCB1—Alzheimer's disease	0.000107	0.00086	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—CDK5—Alzheimer's disease	0.000106	0.000858	CbGpPWpGaD
Masoprocol—CYP19A1—Integrated Breast Cancer Pathway—BAX—Alzheimer's disease	0.000106	0.000854	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—CYP46A1—Alzheimer's disease	0.000106	0.000852	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—NCSTN—Alzheimer's disease	0.000105	0.000847	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—HTR6—Alzheimer's disease	0.000102	0.000826	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—LRP1—Alzheimer's disease	0.000102	0.000826	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism of lipids and lipoproteins—ABCA1—Alzheimer's disease	0.000102	0.000826	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—ND1—Alzheimer's disease	0.000102	0.000823	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—GFAP—Alzheimer's disease	9.99e-05	0.000806	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—GAL—Alzheimer's disease	9.99e-05	0.000806	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism of lipids and lipoproteins—BCHE—Alzheimer's disease	9.96e-05	0.000805	CbGpPWpGaD
Masoprocol—ALOX5—Selenium Micronutrient Network—IL6—Alzheimer's disease	9.96e-05	0.000804	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—PSENEN—Alzheimer's disease	9.28e-05	0.00075	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—APH1A—Alzheimer's disease	9.15e-05	0.000739	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism of lipids and lipoproteins—ABCA1—Alzheimer's disease	9.11e-05	0.000736	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—NCSTN—Alzheimer's disease	8.91e-05	0.00072	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism of lipids and lipoproteins—PPARGC1A—Alzheimer's disease	8.81e-05	0.000712	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—A2M—Alzheimer's disease	8.8e-05	0.000711	CbGpPWpGaD
Masoprocol—LTB4R—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Alzheimer's disease	8.76e-05	0.000708	CbGpPWpGaD
Masoprocol—IGF1R—Insulin Signaling—AKT1—Alzheimer's disease	8.7e-05	0.000703	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—LRP1—Alzheimer's disease	8.69e-05	0.000702	CbGpPWpGaD
Masoprocol—LTB4R—GPCR downstream signaling—PRKCG—Alzheimer's disease	8.68e-05	0.000701	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—PSEN2—Alzheimer's disease	8.52e-05	0.000688	CbGpPWpGaD
Masoprocol—CYP19A1—Integrated Breast Cancer Pathway—ESR1—Alzheimer's disease	8.52e-05	0.000688	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—GAL—Alzheimer's disease	8.49e-05	0.000686	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—GFAP—Alzheimer's disease	8.49e-05	0.000686	CbGpPWpGaD
Masoprocol—LTB4R—GPCR downstream signaling—CCR5—Alzheimer's disease	8.22e-05	0.000664	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—DHCR24—Alzheimer's disease	8.15e-05	0.000658	CbGpPWpGaD
Masoprocol—LTB4R—GPCR downstream signaling—HTR2A—Alzheimer's disease	8.04e-05	0.00065	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism of lipids and lipoproteins—LPL—Alzheimer's disease	8.02e-05	0.000648	CbGpPWpGaD
Masoprocol—LTB4R—Signaling by GPCR—PRKCG—Alzheimer's disease	7.88e-05	0.000636	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism of lipids and lipoproteins—PPARGC1A—Alzheimer's disease	7.85e-05	0.000634	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—NPY—Alzheimer's disease	7.84e-05	0.000633	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—IAPP—Alzheimer's disease	7.79e-05	0.00063	CbGpPWpGaD
Masoprocol—CYP19A1—Integrated Breast Cancer Pathway—CREB1—Alzheimer's disease	7.66e-05	0.000619	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism of lipids and lipoproteins—CHAT—Alzheimer's disease	7.6e-05	0.000614	CbGpPWpGaD
Masoprocol—IGF1R—Focal Adhesion—AKT1—Alzheimer's disease	7.59e-05	0.000613	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—CRH—Alzheimer's disease	7.57e-05	0.000611	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—A2M—Alzheimer's disease	7.48e-05	0.000604	CbGpPWpGaD
Masoprocol—LTB4R—Signaling by GPCR—CCR5—Alzheimer's disease	7.47e-05	0.000603	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—TPI1—Alzheimer's disease	7.37e-05	0.000595	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—CHAT—Alzheimer's disease	7.37e-05	0.000595	CbGpPWpGaD
Masoprocol—LTB4R—Signaling by GPCR—HTR2A—Alzheimer's disease	7.31e-05	0.00059	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—PSEN2—Alzheimer's disease	7.25e-05	0.000585	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—NPS—Alzheimer's disease	7.17e-05	0.000579	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism of lipids and lipoproteins—LPL—Alzheimer's disease	7.15e-05	0.000577	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—PPP3CA—Alzheimer's disease	7.14e-05	0.000577	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—MAOB—Alzheimer's disease	7.06e-05	0.000571	CbGpPWpGaD
Masoprocol—LTB4R—GPCR downstream signaling—F2—Alzheimer's disease	7.05e-05	0.00057	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—PTK2B—Alzheimer's disease	7.04e-05	0.000568	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—CA4—Alzheimer's disease	6.93e-05	0.00056	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—GAB2—Alzheimer's disease	6.84e-05	0.000553	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—NTRK2—Alzheimer's disease	6.84e-05	0.000553	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—SST—Alzheimer's disease	6.84e-05	0.000553	CbGpPWpGaD
Masoprocol—LTB4R—Signaling by GPCR—CALM1—Alzheimer's disease	6.82e-05	0.00055	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—GAPDH—Alzheimer's disease	6.8e-05	0.000549	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—GSK3A—Alzheimer's disease	6.78e-05	0.000548	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism of lipids and lipoproteins—A2M—Alzheimer's disease	6.77e-05	0.000547	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism of lipids and lipoproteins—APOE—Alzheimer's disease	6.72e-05	0.000543	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—NPY—Alzheimer's disease	6.67e-05	0.000539	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—APP—Alzheimer's disease	6.67e-05	0.000539	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism of lipids and lipoproteins—CAV1—Alzheimer's disease	6.66e-05	0.000538	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—IAPP—Alzheimer's disease	6.63e-05	0.000535	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—A2M—Alzheimer's disease	6.57e-05	0.00053	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—CHAT—Alzheimer's disease	6.57e-05	0.00053	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—TPI1—Alzheimer's disease	6.57e-05	0.00053	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—GAPDHS—Alzheimer's disease	6.51e-05	0.000526	CbGpPWpGaD
Masoprocol—CYP19A1—Integrated Breast Cancer Pathway—BCL2—Alzheimer's disease	6.44e-05	0.00052	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—CRH—Alzheimer's disease	6.43e-05	0.00052	CbGpPWpGaD
Masoprocol—LTB4R—Signaling by GPCR—F2—Alzheimer's disease	6.4e-05	0.000517	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—MAOB—Alzheimer's disease	6.3e-05	0.000509	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—PLCB1—Alzheimer's disease	6.29e-05	0.000508	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—ATP5A1—Alzheimer's disease	6.18e-05	0.000499	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—NPS—Alzheimer's disease	6.1e-05	0.000493	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—PPP3CA—Alzheimer's disease	6.07e-05	0.00049	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—GAPDH—Alzheimer's disease	6.06e-05	0.00049	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism of lipids and lipoproteins—APOE—Alzheimer's disease	5.99e-05	0.000484	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—PTK2B—Alzheimer's disease	5.98e-05	0.000483	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism of lipids and lipoproteins—CAV1—Alzheimer's disease	5.94e-05	0.00048	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—PLD3—Alzheimer's disease	5.89e-05	0.000476	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism of lipids and lipoproteins—ACHE—Alzheimer's disease	5.89e-05	0.000476	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—NGFR—Alzheimer's disease	5.87e-05	0.000474	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism of lipids and lipoproteins—PPARG—Alzheimer's disease	5.86e-05	0.000473	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—A2M—Alzheimer's disease	5.85e-05	0.000473	CbGpPWpGaD
Masoprocol—LTB4R—Signaling by GPCR—CREB1—Alzheimer's disease	5.83e-05	0.000471	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism of lipids and lipoproteins—INPP5D—Alzheimer's disease	5.82e-05	0.00047	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—GAB2—Alzheimer's disease	5.82e-05	0.00047	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—SST—Alzheimer's disease	5.82e-05	0.00047	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—NTRK2—Alzheimer's disease	5.82e-05	0.00047	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—GSK3A—Alzheimer's disease	5.77e-05	0.000466	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—ADAM10—Alzheimer's disease	5.73e-05	0.000463	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—ACHE—Alzheimer's disease	5.71e-05	0.000461	CbGpPWpGaD
Masoprocol—LTB4R—Signaling by GPCR—CCL2—Alzheimer's disease	5.71e-05	0.000461	CbGpPWpGaD
Masoprocol—CYP19A1—Integrated Breast Cancer Pathway—CASP3—Alzheimer's disease	5.68e-05	0.000458	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—APP—Alzheimer's disease	5.67e-05	0.000458	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—INPP5D—Alzheimer's disease	5.65e-05	0.000456	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—HSD17B10—Alzheimer's disease	5.65e-05	0.000456	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism of lipids and lipoproteins—PTGS1—Alzheimer's disease	5.52e-05	0.000446	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—CYP46A1—Alzheimer's disease	5.44e-05	0.000439	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—S100B—Alzheimer's disease	5.42e-05	0.000438	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—ENO1—Alzheimer's disease	5.35e-05	0.000432	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—PTGS1—Alzheimer's disease	5.35e-05	0.000432	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—PLCB1—Alzheimer's disease	5.35e-05	0.000432	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—CYP2D6—Alzheimer's disease	5.25e-05	0.000424	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—ND1—Alzheimer's disease	5.25e-05	0.000424	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism of lipids and lipoproteins—PPARG—Alzheimer's disease	5.22e-05	0.000422	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—IGF2—Alzheimer's disease	5.16e-05	0.000417	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism of lipids and lipoproteins—BCHE—Alzheimer's disease	5.13e-05	0.000414	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—ACHE—Alzheimer's disease	5.09e-05	0.000411	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—INPP5D—Alzheimer's disease	5.03e-05	0.000407	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—NGFR—Alzheimer's disease	4.99e-05	0.000403	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—IGF1R—Alzheimer's disease	4.99e-05	0.000403	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—BCHE—Alzheimer's disease	4.98e-05	0.000402	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—ADAM10—Alzheimer's disease	4.88e-05	0.000394	CbGpPWpGaD
Masoprocol—CYP19A1—Integrated Breast Cancer Pathway—VEGFA—Alzheimer's disease	4.82e-05	0.000389	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—LPL—Alzheimer's disease	4.79e-05	0.000387	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—ENO1—Alzheimer's disease	4.77e-05	0.000385	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—PTGS1—Alzheimer's disease	4.77e-05	0.000385	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—MEF2C—Alzheimer's disease	4.74e-05	0.000383	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—PLCB1—Alzheimer's disease	4.7e-05	0.000379	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism of lipids and lipoproteins—ABCA1—Alzheimer's disease	4.69e-05	0.000379	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—CYP2D6—Alzheimer's disease	4.68e-05	0.000378	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—PRKCG—Alzheimer's disease	4.65e-05	0.000376	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—S100B—Alzheimer's disease	4.61e-05	0.000372	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	4.61e-05	0.000372	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—ABCA1—Alzheimer's disease	4.55e-05	0.000368	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—NGF—Alzheimer's disease	4.53e-05	0.000366	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—BCHE—Alzheimer's disease	4.44e-05	0.000358	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—CCR5—Alzheimer's disease	4.41e-05	0.000356	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—IGF2—Alzheimer's disease	4.39e-05	0.000355	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—HTR2A—Alzheimer's disease	4.32e-05	0.000349	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—PLCB1—Alzheimer's disease	4.19e-05	0.000338	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	4.11e-05	0.000332	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—LPL—Alzheimer's disease	4.07e-05	0.000329	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—ABCA1—Alzheimer's disease	4.06e-05	0.000328	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism of lipids and lipoproteins—PPARGC1A—Alzheimer's disease	4.05e-05	0.000327	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—MEF2C—Alzheimer's disease	4.03e-05	0.000326	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—CALM1—Alzheimer's disease	4.03e-05	0.000325	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—APOE—Alzheimer's disease	4.01e-05	0.000324	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—LEP—Alzheimer's disease	4.01e-05	0.000324	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—CAV1—Alzheimer's disease	3.98e-05	0.000321	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—PRKCG—Alzheimer's disease	3.96e-05	0.00032	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—PPARGC1A—Alzheimer's disease	3.92e-05	0.000317	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—HMOX1—Alzheimer's disease	3.91e-05	0.000315	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—NGF—Alzheimer's disease	3.85e-05	0.000311	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—ESR1—Alzheimer's disease	3.83e-05	0.000309	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—F2—Alzheimer's disease	3.78e-05	0.000306	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—CCR5—Alzheimer's disease	3.75e-05	0.000303	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—NOTCH1—Alzheimer's disease	3.7e-05	0.000299	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism of lipids and lipoproteins—LPL—Alzheimer's disease	3.68e-05	0.000297	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—HTR2A—Alzheimer's disease	3.67e-05	0.000296	CbGpPWpGaD
Masoprocol—CYP19A1—Integrated Breast Cancer Pathway—TP53—Alzheimer's disease	3.64e-05	0.000294	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—LPL—Alzheimer's disease	3.57e-05	0.000289	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—PPARGC1A—Alzheimer's disease	3.5e-05	0.000282	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—HMOX1—Alzheimer's disease	3.48e-05	0.000281	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—GSK3B—Alzheimer's disease	3.47e-05	0.000281	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—CREB1—Alzheimer's disease	3.45e-05	0.000278	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—INS—Alzheimer's disease	3.43e-05	0.000277	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—CALM1—Alzheimer's disease	3.42e-05	0.000276	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—APOE—Alzheimer's disease	3.41e-05	0.000276	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—LEP—Alzheimer's disease	3.41e-05	0.000276	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—CHAT—Alzheimer's disease	3.38e-05	0.000273	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—TPI1—Alzheimer's disease	3.38e-05	0.000273	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—CAV1—Alzheimer's disease	3.38e-05	0.000273	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—CCL2—Alzheimer's disease	3.37e-05	0.000272	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—IGF1—Alzheimer's disease	3.32e-05	0.000268	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—ESR1—Alzheimer's disease	3.26e-05	0.000263	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—MAOB—Alzheimer's disease	3.24e-05	0.000262	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—F2—Alzheimer's disease	3.22e-05	0.00026	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—MTHFR—Alzheimer's disease	3.22e-05	0.00026	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—LPL—Alzheimer's disease	3.18e-05	0.000257	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—NOTCH1—Alzheimer's disease	3.15e-05	0.000254	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—GAPDH—Alzheimer's disease	3.12e-05	0.000252	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism of lipids and lipoproteins—APOE—Alzheimer's disease	3.09e-05	0.000249	CbGpPWpGaD
Masoprocol—CYP19A1—Integrated Breast Cancer Pathway—AKT1—Alzheimer's disease	3.07e-05	0.000248	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism of lipids and lipoproteins—CAV1—Alzheimer's disease	3.06e-05	0.000247	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—A2M—Alzheimer's disease	3.02e-05	0.000244	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—NOS3—Alzheimer's disease	3.01e-05	0.000243	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—CALM1—Alzheimer's disease	3.01e-05	0.000243	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—APOE—Alzheimer's disease	2.99e-05	0.000242	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—CAV1—Alzheimer's disease	2.97e-05	0.00024	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—GSK3B—Alzheimer's disease	2.95e-05	0.000239	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—CREB1—Alzheimer's disease	2.93e-05	0.000237	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—INS—Alzheimer's disease	2.91e-05	0.000235	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—CCL2—Alzheimer's disease	2.87e-05	0.000232	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—MTHFR—Alzheimer's disease	2.87e-05	0.000232	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—IGF1—Alzheimer's disease	2.82e-05	0.000228	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism of lipids and lipoproteins—PPARG—Alzheimer's disease	2.69e-05	0.000217	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—CALM1—Alzheimer's disease	2.68e-05	0.000216	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—APOE—Alzheimer's disease	2.67e-05	0.000216	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—CAV1—Alzheimer's disease	2.64e-05	0.000214	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—ACHE—Alzheimer's disease	2.62e-05	0.000212	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—PPARG—Alzheimer's disease	2.61e-05	0.000211	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—INPP5D—Alzheimer's disease	2.59e-05	0.000209	CbGpPWpGaD
Masoprocol—LTB4R—GPCR downstream signaling—AKT1—Alzheimer's disease	2.58e-05	0.000208	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—INS—Alzheimer's disease	2.56e-05	0.000207	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—NOS3—Alzheimer's disease	2.56e-05	0.000206	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—CASP3—Alzheimer's disease	2.55e-05	0.000206	CbGpPWpGaD
Masoprocol—LTB4R—Signaling by GPCR—IL6—Alzheimer's disease	2.54e-05	0.000205	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—ENO1—Alzheimer's disease	2.46e-05	0.000199	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—PTGS1—Alzheimer's disease	2.46e-05	0.000199	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—CYP2D6—Alzheimer's disease	2.41e-05	0.000195	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—MAPK8—Alzheimer's disease	2.35e-05	0.000189	CbGpPWpGaD
Masoprocol—LTB4R—Signaling by GPCR—AKT1—Alzheimer's disease	2.34e-05	0.000189	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—PPARG—Alzheimer's disease	2.32e-05	0.000188	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—BCHE—Alzheimer's disease	2.29e-05	0.000185	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—INS—Alzheimer's disease	2.28e-05	0.000184	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—NOS3—Alzheimer's disease	2.24e-05	0.000181	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—CASP3—Alzheimer's disease	2.17e-05	0.000175	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—VEGFA—Alzheimer's disease	2.17e-05	0.000175	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—PLCB1—Alzheimer's disease	2.16e-05	0.000174	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	2.12e-05	0.000171	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—ABCA1—Alzheimer's disease	2.09e-05	0.000169	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—PTGS2—Alzheimer's disease	2.05e-05	0.000166	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—NOS3—Alzheimer's disease	2e-05	0.000161	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—MAPK8—Alzheimer's disease	1.99e-05	0.000161	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—TGFB1—Alzheimer's disease	1.99e-05	0.000161	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—VEGFA—Alzheimer's disease	1.84e-05	0.000149	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—PTGS2—Alzheimer's disease	1.83e-05	0.000148	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—PPARGC1A—Alzheimer's disease	1.8e-05	0.000146	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—HMOX1—Alzheimer's disease	1.79e-05	0.000145	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—TGFB1—Alzheimer's disease	1.69e-05	0.000136	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—LPL—Alzheimer's disease	1.64e-05	0.000132	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—TP53—Alzheimer's disease	1.64e-05	0.000132	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—IL6—Alzheimer's disease	1.5e-05	0.000121	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—MTHFR—Alzheimer's disease	1.48e-05	0.000119	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—TP53—Alzheimer's disease	1.39e-05	0.000112	CbGpPWpGaD
Masoprocol—LTB4R—Signaling Pathways—AKT1—Alzheimer's disease	1.38e-05	0.000112	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—CALM1—Alzheimer's disease	1.38e-05	0.000111	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—APOE—Alzheimer's disease	1.37e-05	0.000111	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—CAV1—Alzheimer's disease	1.36e-05	0.00011	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—IL6—Alzheimer's disease	1.27e-05	0.000103	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—PPARG—Alzheimer's disease	1.2e-05	9.67e-05	CbGpPWpGaD
Masoprocol—IGF1R—Signaling Pathways—AKT1—Alzheimer's disease	1.17e-05	9.49e-05	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—INS—Alzheimer's disease	1.17e-05	9.49e-05	CbGpPWpGaD
Masoprocol—CYP2J2—Metabolism—AKT1—Alzheimer's disease	1.03e-05	8.33e-05	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—NOS3—Alzheimer's disease	1.03e-05	8.32e-05	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—PTGS2—Alzheimer's disease	9.42e-06	7.61e-05	CbGpPWpGaD
Masoprocol—ALOX5—Metabolism—AKT1—Alzheimer's disease	9.19e-06	7.42e-05	CbGpPWpGaD
Masoprocol—CYP19A1—Metabolism—AKT1—Alzheimer's disease	4.73e-06	3.82e-05	CbGpPWpGaD
